Phacoemulsification & vitrectomy systems

ZEISS QUATERA 700

Excellence Elevated, Redrawing the Boundaries of Phaco.

  • Unmatched stability
  • Game-changing performance
  • Unprecedented efficiency
  • Next-generation innovation
Unmatched stability

Unmatched stability

Unmatched stability

Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981.

Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981.

Unmatched stability

ZEISS QUATERA 700 ensures chamber stability independent of IOP and flow rate ensuring a relaxed surgical experience

ZEISS QUATERA 700’s proprietary ZEISS patented QUATTRO Pump synchronizes infusion and aspiration rates to ensure chamber stability, maintaining IOP with flow rates of up to 90 cc/min (vs. competition´s 50 cc/min), so you can look forward to a more relaxed procedure.1,2,3 ​

In a recent clinical study, mean chamber stability scores were significantly better for ZEISS QUATERA 700 in both soft and dense cataract groups compared to competition.4

  • Active leakage compensation

    Active leakage compensation

    Active leakage compensation

    Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981

    Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981

    Active leakage compensation

    The cutting-edge ZEISS patented QUATTRO Pump introduces revolutionary incision leakage compensation, ensuring maintenance of IOP targets within a remarkably narrow range of ±2 mmHg, over seven times smaller than that of competition1, reducing uncertainty with enhanced stability.

  • ZEISS QUATERA 700 is designed to maintain chamber stability superior over competitive device

    ZEISS QUATERA 700‘s control system when aspirating is better able to compensate for variations in leakage flow when irrigation and aspirating fluid.

Say goodbye to uncertainty

Enter a new era of chamber stability with ZEISS QUATERA 700 and say goodbye to uncertainty

Posterior capsule rupture (PCR) occurs in up to 10% of cataract procedures and vitreous loss in 5%.5,1 So it’s no wonder that the presence of non-dilating pupils, ocular comorbidities, or a fibrotic or breached capsule can impact the confidence of even the most skilled surgeon.5

But what if stability was certain, giving you the freedom to stay focused on surgical intricacies safe in the knowledge that your patient’s safety is diligently attended to? Introducing ZEISS QUATERA 700, featuring the proprietary ZEISS patented QUATTRO Pump. This empowering technology ensures stability irrespective of IOP and flow rate.

In a recent comparative study involving ZEISS QUATERA 700 and competitor phaco devices, PCR occurred in both the soft and dense cataract groups using competitor devices due to surge (chamber shallowing). No PCR incidents were reported with ZEISS QUATERA 700.4

Game-changing performance

Game-changing performance

Game-changing performance

Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981.

Source - Fanney D, et al. Journal of Cataract & Refractive Surgery 2023;49(9):976–981.

Game-changing performance

ZEISS QUATERA 700’s advanced performance sets the stage for elevating surgical standards and delivering cutting-edge ophthalmic solutions

ZEISS QUATERA 700 showcases a vacuum rise time that is more than twice as rapid as competition. With the ability to reinstate IOP within a brisk 300 milliseconds, ZEISS QUATERA 700 surpasses the competition, delivering occlusion break surge control over three times faster at the same vacuum threshold of 600mmHg.6

Surgeons reported ZEISS QUATERA 700 for its unparalleled precision in achieving targeted intraocular pressure (IOP).3 Emulsification of the entire nucleus could be achieved with minimal or no phaco energy in some cases of softer cataract grades using only the high vacuum settings on ZEISS QUATERA 700.4​

In a recent publication, researchers concluded that average phaco and I/A times were significantly lower with ZEISS QUATERA 700 (3.36 ± 0.82 min) compared to the competition (4.14 ± 1.09 min) in dense cataract group.4

Unprecedented efficiency

Enhance workflow and data fluidity with ZEISS QUATERA 700 — a vision of efficiency where advanced integration meets focused care

Unlock the full potential of your OR with ZEISS QUATERA 700's one-data-access feature. Merge information from ZEISS IOLMaster and ZEISS FORUM to conduct paperless timeout checks, fostering a clutter-free environment and improving data management.7

Connecting ZEISS QUATERA 700 to CALLISTO eye® consolidates the number of viewing directions for the sterile nurse, minimizing distractions and sharpening focus.8

  • The future holds more with the ZEISS QUATERA 700

    As we look towards the future of ophthalmic surgery, the demand for technologies that enhance surgical precision and patient safety while reducing operational costs is more pressing than ever.​

    Excessive fluid irrigation & use of too much phaco-energy can result in various complications, be it wound burn, corneal edema or endothelial cell loss.9 ZEISS QUATERA 700, equipped with its innovative POD, is engineered to optimize ultrasound utilization.10

  • Mean fluid turnover

    Mean fluid turnover

    Mean fluid turnover

    Source - Ganesh S, et al. Clin Ophthalmol. 2024;18:2685-2695

    Source - Ganesh S, et al. Clin Ophthalmol. 2024;18:2685-2695

    Lower Fluid usage

    Clinical study results showed that ZEISS QUATERA 700 had significantly lower mean fluid turnover in dense cataract group averaging 7.77 cc less than the competition.4

ZEISS QUATERA 700’s cutting-edge innovation keeps you ahead of the curve

Next-generation innovation

ZEISS QUATERA 700’s cutting-edge innovation keeps you ahead of the curve

Source - Ganesh S, et al. Clin Ophthalmol. 2024;18:2685-2695

Source - Ganesh S, et al. Clin Ophthalmol. 2024;18:2685-2695

Next-generation innovation

ZEISS QUATERA 700’s cutting-edge innovation keeps you ahead of the curve

ZEISS QUATERA 700´s unique features - Power on demand (POD) and Advanced power modulation (APM), both aim at reducing the effective phaco time and total phaco energy used during the surgery.4

In a recent study, featuring ZEISS QUATERA 700, it was observed that the use of APM, combined with relatively higher settings of vacuum, may have resulted in reduced total phaco time (TPT) due to faster and more efficient chopping and emulsification of the nucleus compared to the competition.4

Learn more about ZEISS QUATERA 700

  • QUATERA 700 Comparative Analysis of Chamber Stability Barry S. Seibel et. al Study Spotlight EN

    1 MB
  • QUATERA 700 Comparative Performance Sri Ganesh et al. Study Spotlight EN

    1 MB
  • QUATERA 700 Brochure EN

    1 MB


Get in touch with us!

Receive more information about the product and availability in your country!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice